Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

28 janv. 2016 09h15 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox to Present at LEERINK Partners 5th Annual Global Healthcare Conference

VANCOUVER, British Columbia, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
11 janv. 2016 07h00 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Announces Update on Development Program for AQX-1125 Following Meeting With FDA

VANCOUVER, British Columbia, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
12 mars 2014 12h58 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Announces Closing of Initial Public Offering

VANCOUVER, British Columbia, March 12, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Nasdaq:AQXP) announced today the closing of its initial public offering of 4,830,000 shares of its...
07 mars 2014 09h00 HE | Source: Neoleukin Therapeutics, Inc.

Aquinox Pharmaceuticals Prices Initial Public Offering

VANCOUVER, British Columbia, March 7, 2014 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 4,200,000 shares of its common stock at a...